View Cover
Causing sudden vision loss, this rare but troubling condition is linked to cardiovascular disease.
Modi er 25 + Intravitreal Injections + NCCI Bundles Clinical Applications
Four companies move ahead with trials.
By Jerry Helzner, contributing editor
The retinal physician is often the first to detect it.
Ultra Q Reflex offers new floater strategy
By Stuart Michaelson, Contributing
With a growing body of evidence and a number of models, pattern scanning technology takes off.
18.3% of CATT patients developed GA; Genentech not resting on Lucentis laurels; Allegro’s key drug in two new trials; and more.
A review of the available and forthcoming treatments.
Diagnosis and treatment of this genetic cause of photoreceptor degeneration.
Cleveland Rocks
